Vertex Pharmaceuticals has recently achieved two significant FDA approvals in just 41 days. On December 20, 2024, the FDA approved Alyftrek for treating cystic fibrosis (CF), followed by the approval ...
Subscribe Our Newsletter
“You are my favorite medical source online”
Subscribe to DigimedUpdates for exclusive content and expert insights on all things digital.